Engineering the future of reproductive health.
Despite a growing infertility crisis, reproductive health has received limited focus and investment. Gameto is working on groundbreaking solutions that put women and families first.
First Baby Born Using iPSC Technology
Gameto's iPSC-derived technology is designed to dramatically improve IVF and is showing promise in clinical studies.
Fertilo has not been approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy.
Cell Therapy to Help with Menopause
Despite the fact that over 1 billion women will experience menopause by 2025, few effective treatments exist.
With the help of our recent funding award through ARPA-H's Sprint for Women's Health Initiative, we believe our proprietary cell engineering will help delay the unwanted effects of menopause.
"Next Generation IVF Startup"
Gameto, co-founded by Under 30 alumna Dina Radenkovic, has serious potential. Now it’s finally coming to market.
"Gameto Cleared by FDA to Test Easier IVF Process"
Gameto has received permission from the FDA to investigate whether our ovary-in-a-dish technology can make IVF a less grueling process.

From egg freezing and IVF, to ovarian disease and menopause
Gameto is a first-of-its-kind biotechnology company on a mission to address significant unmet needs for women and families throughout their reproductive years — and beyond.
Transforming reproductive health using modern science
Gameto’s groundbreaking cell engineering platform has the potential to solve many of the problems at the heart of the global infertility crisis.
The first application of our technology, Fertilo, aims to improve the current IVF and egg freezing landscape using engineered ovarian support cells.

Bruna Paulsen, PhD

Dusan Perovic

Martin Varsavsky

Mark Johnson

Samantha Barber
Scientists, innovators, entrepreneurs, parents.
Our team understands firsthand the importance of improving the experience for patients seeking family-building solutions. Our mission to transform reproductive health guides everything we do.
Because women and families deserve more.
Infertility impacts 1 in 6 people worldwide, including our own friends, family, and colleagues. This fight is personal for us, because it’s personal for everyone.
We believe everyone deserves access to solutions that give them the best chance at achieving their family planning goals and dreams.
